-
Mashup Score: 0Lenalidomide Skin Rash May be Marker for Better Survival in Multiple Myeloma - Oncology Nurse Advisor - 14 day(s) ago
The relationship between presence of skin rash and disease progression and survival with lenalidomide treatment was evaluated in patients with multiple myeloma.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Early Antibiotic Use With ICIs Negatively Affects Treatment Efficacy - Oncology Nurse Advisor - 16 day(s) ago
A retrospective analysis of patients with unresectable or metastatic tumors found a window of time relative to ICI initiation in which antibiotics may interfere with the efficacy of immunotherapy.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Antibiotics were found to negatively affect the efficacy of immune checkpoint inhibitors. Reported in @OncJournal. https://t.co/kHRBhEVO6R #cancerresearch
-
-
Mashup Score: 0Benefit of Adjuvant Radiotherapy in Early Breast Cancer May Be Limited to the First Decade - Oncology Nurse Advisor - 17 day(s) ago
Patients with early breast cancer who are at risk of late relapse after breast-conserving surgery may derive little benefit from adjuvant radiotherapy, research suggests.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Patients with early #breastcancer who are at risk of late relapse after breast-conserving surgery may derive little benefit from adjuvant radiotherapy. Published in @TheLancetOncol and @CancerTherAdvsr. https://t.co/AF2qJNQUHZ #bcsm
-
-
Mashup Score: 0
Researchers conducted a retrospective cohort study to assess the link between nonfunctional adrenal tumors and cancer risk.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, NursingTweet-
Individuals with nonfunctional adrenal #tumors have an increased risk of developing #cancer. Published in @EndoAdvisor. https://t.co/Vynv3DjT0x
-
-
Mashup Score: 0Decitabine Plus Venetoclax and Ponatinib Demonstrates Activity in Advanced Phase CML - Oncology Nurse Advisor - 19 day(s) ago
Decitabine plus venetoclax and ponatinib appeared safe and elicited responses in a phase 2 trial of patients with advanced phase CML.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The combination of decitabine, venetoclax, and ponatinib appeared safe and elicited responses in a phase 2 trial of patients with advanced phase chronic myeloid #leukemia. Reported in @TheLancet and @CancerTherAdvsr. https://t.co/gyHhIW4EPa #CML
-
-
Mashup Score: 0Risk of Adverse Effects With Treosulfan HDCT Greater for Female Patients With MM - Oncology Nurse Advisor - 20 day(s) ago
A review of data demonstrated that female patients with MM experience worse adverse effects, PFS, and OS with higher treosulfan doses, compared with male patients.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Female patients with #multipleMyeloma may benefit from lower doses of treosulfan when undergoing high-dose chemotherapy followed by ASCT. https://t.co/jbSVTwTg5l
-
-
Mashup Score: 1
A patient’s delayed cancer diagnosis led to a medical malpractice lawsuit against her primary care doctor and endocrinologist.
Source: www.endocrinologyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet-
A patient sued her primary care doctor and #endocrinologist after a delayed diagnosis of Stage IV #thyroidcancer. From @EndoAdvisor. https://t.co/vlRR3dTiiP #thcsm
-
-
Mashup Score: 1
A patient’s delayed cancer diagnosis led to a medical malpractice lawsuit against her primary care doctor and endocrinologist.
Source: www.endocrinologyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet-
A patient sued her primary care doctor and #endocrinologist after a delayed diagnosis of Stage IV #thyroidcancer. From @EndoAdvisor. https://t.co/vlRR3dTiiP #thcsm
-
-
Mashup Score: 0Integrated Narrative Program Enhances Patient Resilience, NSCLC Outcomes - Oncology Nurse Advisor - 21 day(s) ago
Researchers conduct experimental trial to explore the effectiveness of combining 2 proven narrative therapies to improve resilience, self-efficacy, and QOL in patients with NSCLC.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
An integrated narrative program was more effective at improving QOL in patients who have undergone surgical treatment of non-small cell #lungcancer than a digital storytelling intervention. https://t.co/y38EPuIDT3 #NSCLC #lcsm
-
-
Mashup Score: 0Malnutrition Screening With Validated Tools Advised for All Patients in Outpatient Cancer Clinics - Oncology Nurse Advisor - 23 day(s) ago
In a review of studies, researchers identified the need for malnutrition screening and recommended 6 validated tools for nutritional assessment in the outpatient setting.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Clinicians could improve #malnutrition among adult ambulatory #oncology patients by incorporating validated screening tools, according to a study published by @aspenweb. https://t.co/qflAJQ3HJ3
-
Skin rash during lenalidomide treatment was identified as a predictor for prolonged survival among patients with #multipleMyeloma. https://t.co/IW2Oe6dMA6